Tech Company Financing Transactions

Alpine Immune Sciences Funding Round

On 6/14/2016, Alpine Immune Sciences received $48 million in Series A funding from OrbiMed, Alpine Technology Fund and Frazier Healthcare Partners.

Transaction Overview

Announced On
6/14/2016
Transaction Type
Venture Equity
Amount
$48,000,000
Round
Series A
Investors

OrbiMed (Lead Investor) (Peter Thompson)

Alpine Technology Fund

Frazier Healthcare Partners (Jamie Toppe)

Proceeds Purpose
We believe this significant funding, along with our collective expertise, will enable us to discover and develop clinically meaningful and transformative therapies for patients.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 Elliott Ave. W 230
Seattle, WA 98119
USA
Email Address
Not Recorded
Overview
Alpine Immune Sciences (AIS) was founded in 2015 and seed funded by Alpine BioVentures. AIS is focused on developing novel protein - based immunotherapies using its proprietary variant immunoglobulin domain (vIgD) platform technology.
Profile
Alpine Immune Sciences LinkedIn Company Profile
Social Media
Alpine Immune Sciences Company Twitter Account
Company News
Alpine Immune Sciences News
Facebook
Alpine Immune Sciences on Facebook
YouTube
Alpine Immune Sciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mitchell Gold
  Mitchell Gold LinkedIn Profile  Mitchell Gold Twitter Account  Mitchell Gold News  Mitchell Gold on Facebook
Chief Financial Officer
Paul Rickey
  Paul Rickey LinkedIn Profile  Paul Rickey Twitter Account  Paul Rickey News  Paul Rickey on Facebook
Chief Technical Officer
Wayne Gombotz
  Wayne Gombotz LinkedIn Profile  Wayne Gombotz Twitter Account  Wayne Gombotz News  Wayne Gombotz on Facebook
VP - Bus. Development
Jan Hillson
  Jan Hillson LinkedIn Profile  Jan Hillson Twitter Account  Jan Hillson News  Jan Hillson on Facebook
VP - R & D
Stanford Peng
  Stanford Peng LinkedIn Profile  Stanford Peng Twitter Account  Stanford Peng News  Stanford Peng on Facebook
VP - R & D
Kristine Swiderek
  Kristine Swiderek LinkedIn Profile  Kristine Swiderek Twitter Account  Kristine Swiderek News  Kristine Swiderek on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/14/2016: Bipsync venture capital transaction
Next: 6/14/2016: Chronext venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary